Epidemiology and burden of prosthetic joint infections

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue SUPPL1, 2014, Pages

  Lamagni, Theresa ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Hip prosthesis; Knee prosthesis; Surgical wound infection

Indexed keywords

ADVERSE EFFECTS; ARTHROPLASTY; EPIDEMIOLOGICAL MONITORING; HUMAN; INFECTION CONTROL; OSTEOARTHRITIS; PROSTHESIS-RELATED INFECTIONS; RISK FACTOR;

ARTHROPLASTY; EPIDEMIOLOGICAL MONITORING; HUMANS; INFECTION CONTROL; OSTEOARTHRITIS; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS;

EID: 84906829117     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku247     Document Type: Article

References (40)

1. European Centre for Disease Prevention and Control. Surveillance of Surgical Site Infections in Europe, 2008-2009. http://ecdc.europa.eu/en/publications/Publications/120215_SUR_SSI_2008-2009.pdf (17 April 2013, date last accessed).
2. European Centre for Disease Prevention and Control. Surveillance of Surgical Site Infections in European Hospitals-HAISSI Protocol. Version 1.02. http://www.ecdc.europa.eu/en/publications/Publications/120215_TED_SSI_protocol.pdf (10 April 2013, date last accessed).
3. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-32.
4. Paxton EW, Furnes O, Namba RS et al. Comparison of the Norwegian knee arthroplasty register and a United States arthroplasty registry. J Bone Joint Surg Am 2011; 93 Suppl 3: 20-30.
5. National Joint Registry for England and Wales. 9th Annual Report. http://www.njrcentre.org.uk/NjrCentre/Portals/0/Documents/England/Reports/9th_annual_report/NJR%209th%20Annual%20Report%202012.pdf (3 April 2013, date last accessed).
6. Health Protection Agency. English National Point Prevalence Survey on Healthcare-associated Infections and Antimicrobial Use, 2011: Preliminary Data. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317134304594 (3 April 2013, date last accessed).
7. Health Protection Agency. Surveillance of Surgical Site Infection in NHS Hospitals in England 2011/12. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317137334452 (3 April 2013, date last accessed).
8. OECD. Hip and knee replacement. In: Health at a Glance 2011: OECD Indicators. Paris: OECD Publishing, 2011.
9. Cahill JL, Shadbolt B, Scarvell JM et al. Quality of life after infection in total joint replacement. J Orthop Surg (Hong Kong) 2008; 16: 58-65.
10. Bozic KJ, Kurtz SM, Lau E et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res 2010; 468: 45-51.
11. Bozic KJ, Kurtz SM, Lau E et al. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am 2009; 91: 128-33.
12. Mangram AJ, Horan TC, Pearson ML et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20: 250-78.
13. Poultsides LA, Ma Y, Della Valle AG et al. In-hospital surgical site infections after primary hip and knee arthroplasty-incidence and risk factors. J Arthroplasty 2013; 28: 385-9.
14. Coello R, Charlett A, Wilson J et al. Adverse impact of surgical site infections in English hospitals. J Hosp Infect 2005; 60: 93-103.
15. Kurtz SM, Lau E, Schmier J et al. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008; 23: 984-91.
16. Whitehouse JD, Friedman ND, Kirkland KB et al. The impact of surgicalsite infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002; 23: 183-9.
17. Hebert CK, Williams RE, Levy RS et al. Cost of treating an infected total knee replacement. Clin Orthop Relat Res 1996; 331: 140-5.
18. Bozic KJ, Katz P, Cisternas M et al. Hospital resource utilization for primary and revision total hip arthroplasty. J Bone Joint Surg Am 2005; 87: 570-6.
19. Klouche S, Sariali E, Mamoudy P. Total hip arthroplasty revision due to infection: a cost analysis approach. Orthop Traumatol Surg Res 2010; 96: 124-32.
20. Public Health England. Protocol for the Surveillance of Surgical Site Infection. Version 6 June 2013. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1194947388966 (28 June 2013, date last accessed).
21. Ong KL, Kurtz SM, Lau E et al. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty 2009; 24: 105-9.
22. Kurtz SM, Ong KL, Lau E et al. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res 2010; 468: 52-6.
23. Peel TN, Cheng AC, Buising KL et al. Microbiological aetiology, epidemiology, and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective? Antimicrob Agents Chemother 2012; 56: 2386-91.
24. Hidron AI, Edwards JR, Patel J et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29: 996-1011.
25. Department of Health. Screening for Meticillin-resistant Staphylococcus aureus (MRSA) Colonisation. A Strategy for NHS Trusts: A Summary of Best Practice. London: Department of Health, 2006.
26. Department of Health. MRSA Screening-Operational Guidance. London: Department of Health, 2008.
27. Johnson AP, Davies J, Guy R et al. Mandatory surveillance of methicillinresistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother 2012; 67: 802-9.
28. Berbari EF, Osmon DR, Lahr B et al. The Mayo prosthetic joint infection risk score: implication for surgical site infection reporting and risk stratification. Infect Control Hosp Epidemiol 2012; 33: 774-81.
29. Bozic KJ, Lau E, Kurtz S et al. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am 2012; 94: 794-800.
30. Bozic KJ, Lau E, Kurtz S et al. Patient-related risk factors for postoperative mortality and periprosthetic joint infection in Medicare patients undergoing TKA. Clin Orthop Relat Res 2012; 470: 130-7.
31. Schweizer M, Perencevich E, McDanel J et al. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis. BMJ 2013; 346: f2743.
32. Breier AC, Brandt C, Sohr D et al. Laminar airflow ceiling size: no impact on infection rates following hip and knee prosthesis. Infect Control Hosp Epidemiol 2011; 32: 1097-102.
33. Hooper GJ, Rothwell AG, Frampton C et al. Does the use of laminar flow and space suits reduce early deep infection after total hip and knee replacement? The ten-year results of the New Zealand Joint Registry. J Bone Joint Surg Br 2011; 93: 85-90.
34. Edwards JR, Peterson KD, Mu Y et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009; 37: 783-805.
35. Brummer S, Brandt C, Sohr D et al. Does stratifying surgical site infection rates by the National Nosocomial Infection Surveillance risk index influence the rank order of the hospitals in a surveillance system? J Hosp Infect 2008; 69: 295-300.
36. Gastmeier P. European perspective on surveillance. J Hosp Infect 2007; 65 Suppl 2: 159-64.
37. Calderwood MS, Ma A, Khan YM et al. Use of Medicare diagnosis and procedure codes to improve detection of surgical site infections following hip arthroplasty, knee arthroplasty, and vascular surgery. Infect Control Hosp Epidemiol 2012; 33: 40-9.
38. Lamagni T, Elgohari S, Mihalkova M et al. Impact of surgical site infection on patient mortality, England 2010/11. In: Abstracts of IDWeek 2012, San Diego, CA, 2012. Abstract 1657, p. 107. Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, HIV Medicine Association, Pediatric Infectious Diseases Society, Arlington, VA, USA.
39. Department of Health. Public Health Surveillance-Towards a Strategy for Public Health England. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/127475/Towards-a-Public-Health-Surveillance-Strategy.pdf.pdf (10 April 2013, date last accessed).
40. Hall L, Halton K, Bailey EJ et al. Post-discharge surgical site surveillance-where to from here? J Hosp Infect 2013; 84: 268.